Synthon Hispania, S.L. (packaging, quality control, batch release unit)
UkraineAll drugs from this manufacturer
-
The drug is used to treat adult patients with multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04